Hypoxic-ischemic brain injury in the perinatal period is a major cause of morbidity and mortality. Presently, there are no proven effective therapies with which to safeguard the human neonatal brain against this type of injury. Minocycline, a semisynthetic tetracycline, has been shown to be neuropro
Minocycline: A neuroprotective agent for hypoxic-ischemic brain injury in the neonate?
✍ Scribed by Kathryn M. Buller; Michelle L. Carty; Hanna E. Reinebrant; Julie A. Wixey
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 135 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Minocycline is a second‐generation tetracycline and a potential neuroprotective intervention following brain injury. However, despite the recognized beneficial effects of minocycline in a multitude of adult disease states, the clinical application of minocycline in neonates is contentious. Tetracyclines, as a class, are not usually administered to neonates, but there is compelling evidence that minocycline reduces brain injury after neonatal hypoxic‐ischemic brain injury. This Review focuses on the evidence for minocycline use in neonates by considering aspects of pharmacology, drug regimens, functional outcomes, and mechanisms of action. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Iron can contribute to hypoxic-ischemic brain damage by catalyzing the formation of free radicals. The immature brain has high iron levels and limited antioxidant defenses. The objective of this study was to describe the early alterations in nonheme iron histochemistry following a hypoxic-ischemic (
The remarkable advances in survival of infants with congenital heart disease who undergo cardiac surgery are due in large part to techniques that require periods of markedly decreased or arrested circulation. An obvious prerequisite has been the development of techniques that protect critical organ
## Abstract __In vivo__ lactate detection using gradient enhanced double quantum coherence transfer (DQCT) was significantly improved by addition of short‐time‐inversion‐recovery (STIR). Phantom studies demonstrated lipid suppression down to the background noise level with 33% loss of lactate signa
## Abstract We examined the effect of treatment with intraventricular injection of a decoy oligonucleotide that binds and inhibits nuclear factor‐κB on cytokine expression, ICAM‐1 expression, neutrophil recruitment, apoptosis, and tissue injury in a model of neonatal hypoxic‐ischemic cerebral injur